2 results match your criteria: "Centre Munich University of Munich[Affiliation]"
Lung Cancer Screening in Persons Who Never Smoked Has to be Evaluated-A Response to Letter to the Editor.
J Thorac Oncol
February 2022
Division of Respiratory Medicine and Thoracic Oncology Thoracic Oncology, LMU Klinikum der Universität München-Campus Innenstadt, Centre Munich University of Munich, Munich, Germany.
Screening for Lung Cancer in Individuals Who Never Smoked: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report.
J Thorac Oncol
January 2022
Division of Respiratory Medicine and Thoracic Oncology, Department of Internal Medicine V Thoracic Oncology Centre Munich University of Munich-Campus Innenstadt Munich, Germany, member of the German Center for Lung Research (DZL - CPC-M).
Screening with low-dose computed tomography of high-risk individuals with a smoking history reduces lung cancer mortality. Current screening guidelines and eligibility criteria can miss more than 50% of lung cancers, and in some geographic areas, such as East Asia, a large proportion of the missed lung cancers are in never-smokers. Although randomized trials revealed the benefits of screening for people who smoke, these trials generally excluded never-smokers.
View Article and Find Full Text PDF